SCHEMBL27915706

SCHEMBL27915706

COc1ccc(-c2ncoc2-c2ccncc2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 1/20 0.56
▸ NPC1 O15118 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ S1PR1 P21453 1/20 0.44
▸ S1PR3 Q99500 1/20 0.44
▸ PDE4A P27815 1/20 0.44
▸ GSK3B P49841 1/20 0.44
▸ TUBB4A P04350 1/20 0.44
▸ TUBB P07437 1/20 0.44
▸ TUBA3C P0DPH7 1/20 0.44
▸ TUBA1B P68363 1/20 0.44
▸ TUBA4A P68366 1/20 0.44
▸ TUBB4B P68371 1/20 0.44
▸ TUBB3 Q13509 1/20 0.44
▸ TUBB2A Q13885 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27820749 0.82 GSK3B (0.48) MAPK14NPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL27820762 0.81 MAPT (0.47) MAPTALDH1A1HPGDMAPK1L3MBTL1
SCHEMBL28807093 0.80 HDAC1 (0.48) MAPTSMN1; SMN2ALDH1A1HPGDMAPK1
2-Mercaptoethanol SCHEMBL11753567 0.80 HDAC1 (0.48) MAPTALDH1A1HPGDMAPK1L3MBTL1
SCHEMBL11757371 0.77 HDAC1 (0.48) NPC1MAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL11755900 0.76 L3MBTL1 (0.48) MAPK14NPC1MAPTALDH1A1HPGD
SCHEMBL11330797 0.76 MAPT (0.61) NPC1MAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL1387297 0.75 MAPK14 (0.60) MAPK14ALDH1A1HPGDGSK3B
SCHEMBL4070477 0.74 TUBB4A (0.44) MAPK14SMN1; SMN2ALDH1A1HPGDMAPK1
SCHEMBL27840095 0.73 GSK3B (0.43) MAPK14NPC1SMN1; SMN2ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102190625-B Stilbene tumor targeted medicine Combretastatin A4 analogs NANJING SANHOME PHARMACEUTICAL CO LTD 2013-08-28 — — CN claimed
CN-102190625-B Stilbene tumor targeted medicine Combretastatin A4 analogs NANJING SANHOME PHARMACEUTICAL CO LTD 2013-08-28 — — CN disclosed
Send feedback